Industry Insights

  1. Selecting The Best Human Factors Method For Your Medical Or Drug Delivery Device Evaluation 7/21/2021

    A robust human factors process is critical to product optimization and market competitiveness for medical devices and drug delivery devices, but not all companies have the resources, funding, or time to conduct such user studies. Genentech's head of human factors engineering examines the three major categories of evaluation that you should consider, the pros and cons of each, and how to select study participants.

  2. Sourcing Pharmaceutical And Industrial Equipment In Auctions 5/9/2025

    More and more industrial gear is hitting the auction block. Unlock significant savings by understanding the nuances of pharmaceutical and industrial equipment auctions.

  3. Extending Quality Management Through Vendor Compliance Audits 5/25/2023

    Explore the primary responsibilities of both manufacturers and vendors during a vendor compliance audit, as well as practical strategies and tools, including audit management software, that make them possible.

  4. Upping Flow Of Advanced Technologies Into Commercial Biomanufacturing 9/12/2024

    A set of tools NASA developed assessing new, rapidly developed and deployed technology could help biopharmas adopt advanced tech post-commercialization.

  5. COVID-19's Impact On Availability Of Drugs And API From India And China 4/23/2020

    COVID-19 has caused an increase in demand for APIs and drugs; those used as antimalarials are seeing the highest demand, followed by bronchodilators, antibiotics, and antivirals. This article reviews the drugs and API in demand globally, with assessments of their supply status in India and China.

  6. Why You Need A World-Class Quality Culture — And How To Build One 1/13/2020

    The quality culture of the organization has a clear and direct impact on the ultimate quality of the product. This article discusses several ideas for implementing a quality culture that is based on innovation while ensuring compliance with regulations.

  7. Novel amplification technology to challenge PCR in diagnostics 8/21/2000
    With PCR sitting pretty as king of the hill in nucleic acid amplification, who needs a competing technology?...
  8. DSCSA Implementation Is Progressing, But More Complexity May Be Coming 8/5/2024

    The FDA recently announced it would exempt small dispensers from requirements of the Drug Supply Chain Security Act (DSCSA) until Nov. 27, 2026. The industry has made tremendous progress so far with DSCSA, but this discretion will make compliance more challenging.

  9. AI-Powered Digital Pathology For Pulmonary Fibrosis Biomarker Quantification 3/27/2025

    Uncover how AI-driven digital pathology is revolutionizing the detection and quantification of pulmonary fibrosis markers in whole lung sections, offering new opportunities for clinical research.

  10. Multispecific Trial Supply Stability Hinges On CDMO Agility 6/10/2025

    Naya's CEO describes the dynamics of producing a complex therapeutic for clinical trials on another continent, and how choice of CDMO plays heavily into that strategy.